QuidelOrtho Announces Preliminary Unaudited Revenue for 4Q 2024
January 14, 2025
January 14, 2025
SAN DIEGO, California, Jan. 14 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release on Jan. 13, 2025:
* * *
Top-line Results In Line with Expectations; Company Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
* * *
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or &q . . .
* * *
Top-line Results In Line with Expectations; Company Expects to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
* * *
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or &q . . .